Back to Journals » Open Access Medical Statistics » Volume 2

Setting sample size using cost efficiency in fMRI studies

Authors Guo Q, Hall G, McKinnon M, Thabane L, Goeree R, Pullenayegum E

Received 13 February 2012

Accepted for publication 22 March 2012

Published 21 May 2012 Volume 2012:2 Pages 33—41

DOI https://doi.org/10.2147/OAMS.S30830

Review by Single-blind

Peer reviewer comments 4

Qing Guo,1,3 Geoffrey Hall,2 Margaret McKinnon,2,4,7 Lehana Thabane,1,3,5 Ron Goeree,1,5,6 Eleanor Pullenayegum1,3,5

1Department of Epidemiology and Biostatistics, 2Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, ON, Canada; 3Biostatistics Unit, 4Mood Disorders Program, 5Center for Evaluation of Medicine, 6Programs for Assesment of Technology in Health (PATH) Research Institute, St, Joseph’s Healthcare, Hamilton, ON, Canada; 7Kunin-Lunenfeld Applied Research Unit, Baycrest, Toronto, ON, Canada

Background: Sample size calculations are rarely performed for functional magnetic resonance imaging studies involving clinical populations. This may be due to uncertainty as to the size of expected effect and the variance of the blood oxygenation level dependent response. Moreover, existing sample size methods ignore the costs associated with performing the proposed study. The current paper describes how cost efficiency, a recently proposed method, can be used in conjunction with existing methods to address these issues.
Methods: Cost efficiency is the ratio of a study’s value to its cost, and sample size is chosen to maximize cost efficiency (ie, to maximize return on investment). It is suggested that sample size calculations begin by calculating the sample sizes required to achieve a given power, through varying the input parameters to the calculation over their plausible ranges. Cost efficiency can then help narrow the resulting range of sample sizes and help choose one sample size. The approach is illustrated through a recent functional magnetic resonance imaging study of autobiographical memory retrieval in patients with major depressive disorder.
An example: Setting power to 80% and type 1 error rate to 5%, the method of Mumford and Nichols was used to calculate sample size. There were no reported effect sizes for similar studies in the literature; consequently, this parameter was varied over its plausible range (Cohen’s d varying from 0.2 to 0.8). This yielded sample sizes ranging from 50 to 800. Within these, cost efficiency gave a sample size of 88.
Conclusion: Poor reporting of the input parameters to power-based methods of sample size determination results in a wide range of candidate sample sizes. The cost efficiency approach supplies a way of narrowing this range and choosing a sample size from that.

Keywords: cost efficiency, sample size, power, fMRI studies

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Chloramphenicol encapsulated in poly-ε-caprolactone–pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds

Kalita S, Devi B, Kandimalla R, Sharma KK, Sharma A, Kalita K, Kataki AC, Kotoky J

International Journal of Nanomedicine 2015, 10:2971-2984

Published Date: 15 April 2015

Toxicology of antimicrobial nanoparticlesfor prosthetic devices

Nuñez-Anita RE, Acosta-Torres LS, Vilar-Pineda J, Martínez-Espinosa JC, de la Fuente-Hernández J, Castaño VM

International Journal of Nanomedicine 2014, 9:3999-4006

Published Date: 20 August 2014

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China

Cai BQ, Cai SX, Chen RC, Cui LY, Feng YL, Gu YT, Huang SG, Liu RY, Liu GN, Shi HZ, Shi Y, Song YL, Sun TY, Wang CZ, Wang JL, Wen FQ, Xiao W, Xu YJ, Yan XX, Yao WZ, Yu Q, Zhang J, Zheng JP, Liu J, Bai CX

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:381-395

Published Date: 25 April 2014

Response to vitamin D and depression in geriatric primary care patients

Muc-Wierzgoń M, Nowakowska-Zajdel E, Klakla K, Dzięgielewska-Gęsiak S, Fatyga E, Kokot T

Clinical Interventions in Aging 2013, 8:825-827

Published Date: 3 July 2013

Current and future initiatives for vascular health management in clinical practice

Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J

Vascular Health and Risk Management 2013, 9:255-264

Published Date: 28 May 2013

Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence

Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ

Neurobehavioral HIV Medicine 2012, 4:113-121

Published Date: 18 October 2012

Association between calcifying nanoparticles and placental calcification

Guo Y, Zhang D, Lu H, Luo S, Shen X

International Journal of Nanomedicine 2012, 7:1679-1686

Published Date: 27 March 2012

Practical recommendations for treatment of hypertension in older patients

Philip A Kithas, Mark A Supiano

Vascular Health and Risk Management 2010, 6:561-569

Published Date: 29 June 2010

Bactericidal effects of silver plus titanium dioxide-coated endotracheal tubes on Pseudomonas aeruginosa and Staphylococcus aureus

Keiko M Tarquinio, Nikhil K Kothurkar, Dharendra Y Goswami, et al

International Journal of Nanomedicine 2010, 5:177-183

Published Date: 16 March 2010